Abstract
Background The immune response to infections could be largely driven by the individual’s genes, especially in the major histocompatibility complex (MHC) region. Varicella-zoster virus (VZV) is a highly communicable pathogen. In addition to infection, the re-activations of VZV can be a potential causal factor for multiple traits. Identification of VZV immune response-related health conditions can therefore help elucidate the aetiology of certain diseases.
Methods A phenome-wide Mendelian randomization study (MR-PheWAS) of anti-VZV Immunoglobulin G (IgG) level with 1,370 traits was conducted to explore the potential causal role of VZV-specific immunity on multiple traits using the UK Biobank cohort. For each trait, we performed Mendelian randomization (MR) analyses using five methods with or without instrumental variables (IVs) in the MHC region.
Results We identified 49 single nucleotide polymorphisms (SNPs) associated with anti-VZV IgG level as IVs, five of which were located in the MHC region. Statistical evidence for a causal effect of anti-VZV IgG level on 75 traits was found in at least three of the MR methods, 60 traits if IVs in the MHC region were removed from MR analysis. With or without the MHC IVs, we found that a higher anti-VZV IgG level led to increased risk of 14 diseases and lower risks of 9 diseases. In addition, anti-VZV IgG level was causally associated with 5 biomarker-related traits.
Conclusions Anti-VZV IgG was causally associated with multiple traits. MHC IVs had a substantial impact on MR causal inference, and therefore, should not be neglected from analysis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
XY, KRM, AL and KM are supported by the Advantage Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Publicly available data from the UK Biobank study was analysed in this study. The datasets are available to researchers through an open application via https://www.ukbiobank.ac.uk/register-apply/. Publicly available GWAS summary statistics used in this study is available in http://www.nealelab.is/uk-biobank.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵# Joint senior authors
Data Availability
Publicly available data from the UK Biobank study was analysed in this study. The datasets are available to researchers through an open application via https://www.ukbiobank.ac.uk/register-apply/. Publicly available GWAS summary statistics used in this study is available in http://www.nealelab.is/uk-biobank.
List of abbreviations
- BP
- blood pressure
- CNS
- central nervous system
- GWAS
- genome-wide association study
- HZO
- herpes zoster ophthalmicus
- IgG
- immunoglobulin G
- LD
- linkage disequilibrium
- MAF
- minor allele frequency
- MHC
- histocompatibility complex
- MR-PheWAS
- mendelian randomization phenome-wide association study
- SLE
- systemic lupus erythematosus
- SNP
- single nucleotide polymorphisms
- VZV
- varicella-zoster virus
